[Federal Register Volume 66, Number 213 (Friday, November 2, 2001)]
[Notices]
[Page 55641]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-27627]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Intent To Grant an Exclusive License of a U.S. 
Government-Owned Patent; Correction

AGENCY: U.S. Army Medical Research and Materiel Command, DOD.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The U.S. Army Medical Research and Materiel Command published 
a document in the Federal Register of October 18, 2001, concerning 
intent to grant an exclusive license of a U.S. Government-owned patent. 
Inadvertently, the incorrect information was provided under the 
summary.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

Correction

    In the Federal Register of Oct 18, 2001, in FR Doc. 01-26191, on 
page 52898, in the second column, correct the SUMMARY caption to read:

SUMMARY: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), 
announcement is made of the intent to grant an exclusive, royalty-
bearing, revocable license to U.S. patent number 5,607,979 issued March 
4, 1997 entitled ``Topical Skin Protectants'' to DFB Pharmaceuticals, 
Inc with its principal place of business at 3909 Hulen Street, Fort 
Worth, Texas 76107.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 01-27627 Filed 11-1-01; 8:45 am]
BILLING CODE 3710-08-M